A double-blind, randomized, multicenter study to evaluate the effectiveness of the combination of valsartan and amlodipine in hypertensive patients not controlled on monotherapy.
Phase of Trial: Phase III
Latest Information Update: 23 Feb 2017
At a glance
- Drugs Amlodipine/valsartan (Primary)
- Indications Hypertension
- Focus Registrational; Therapeutic Use
- Sponsors Novartis
- 07 Nov 2011 Actual patient number is 894 according to ClinicalTrials.gov.
- 07 Nov 2011 Actual end date (1 Jan 2007) added as reported by ClinicalTrials.gov.
- 07 Nov 2011 Last checked against ClinicalTrials.gov record.